The incidence of thyroid cancer worldwide is increasing. It is the commonest endocrine malignancy but represents only 1% of all cancers. Whereas the prognosis of differentiated thyroid cancer is good, the survival time of anaplastic thyroid cancer and of medullary thyroid cancer is still very short. More precise diagnosis with better stratification of patients and identification of risk patients as well as personalized treatment may improve the prognosis of thyroid cancer. Treatment of thyroid cancer is multidisciplinary and involves endocrinologists, nuclear medicine specialists, and surgeons, and the special issue aims to collect contributions from these different fields.

We invite investigators to contribute original articles and review articles addressing advances in diagnosis and therapy of all types of differentiated thyroid cancer, anaplastic thyroid cancer, and medullary thyroid cancer. The submission of manuscript on innovative approaches (e.g., diagnostic and therapeutic nanoparticles, gene therapy, new targets for differentiation therapy) is highly encouraged. Potential topics include, but are not limited to:

• Risk factors for thyroid cancer
• Role of immune cells (e.g., regulatory T cells)
• New in vitro and animal models for thyroid cancer
• Imaging options in thyroid cancer
• Molecular diagnosis of thyroid cancer
• Predictive (bio)markers for thyroid cancer
• Histopathological tools for improved diagnosis
• Targeted therapies (e.g., tyrosine kinase inhibitors, antiangiogenesis drugs), immunotherapy, peptide receptor radionuclide therapy, and innovative formulations for thyroid cancer
• Improved protocols in surgical resection, radiation, and radioiodine treatment
• Clinical studies of rare thyroid cancer manifestations

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ije/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: